New viral vectors for infectious diseases and cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New viral vectors for infectious diseases and cancer

Published:2020-08 Issue: Volume:50 Page:101430
ISSN:1044-5323
Container-title:Seminars in Immunology
language:en
Short-container-title:Seminars in Immunology

Author:

Sasso Emanuele,D’Alise Anna Morena,Zambrano Nicola,Scarselli Elisa,Folgori Antonella,Nicosia Alfredo

Funder

SATIN, Regione Campania

CEINGE TASK-FORCE COVID-19

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference342 articles.

1. History of vaccination;Plotkin;Proc Natl Acad Sci U S A,2014

2. Antimicrobial resistance and the role of vaccines;Bloom;Proc Natl Acad Sci U S A,2018

3. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!);Henao-Restrepo;Lancet,2017

4. Molecular mechanisms for enhanced DNA vaccine immunogenicity;Li;Expert Rev. Vaccines,2016

5. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity;Suschak;Hum. Vaccin. Immunother.,2017

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity;International Immunopharmacology;2024-12

2. Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector;Frontiers in Immunology;2024-09-12

3. Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells;Expert Review of Vaccines;2024-09

4. Development and applications of lipid hydrophilic headgroups for nucleic acid therapy;Biotechnology Advances;2024-09

5. The first case of multiple myeloma treated with ASCT followed by Anti-BCMA CAR-T cells using retrovirus vector: A case report;Heliyon;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3